Electrocardiogram Detection of Pulmonary Hypertension Using Deep Learning.

Journal: Journal of cardiac failure
Published Date:

Abstract

BACKGROUND: Pulmonary hypertension (PH) is life-threatening, and often diagnosed late in its course. We aimed to evaluate if a deep learning approach using electrocardiogram (ECG) data alone can detect PH and clinically important subtypes. We asked: does an automated deep learning approach to ECG interpretation detect PH and its clinically important subtypes?

Authors

  • Mandar A Aras
    Department of Medicine (G.H.T., M.H.L., E.F., M.A.A., C.J., K.E.F., R.C.D.).
  • Sean Abreau
  • Hunter Mills
    Bakar Computation Health Sciences Institute, University of California, San Francisco, San Francisco, California.
  • Lakshmi Radhakrishnan
    Bakar Computation Health Sciences Institute, University of California, San Francisco, San Francisco, California.
  • Liviu Klein
    From the School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta (O.T.I., M.B.P., A.Q.J., A.D., A.O.B.); Division of Cardiology (S.D., T.D.M., L.K.) and Department of Bioengineering and Therapeutic Sciences (S.R.), University of California, San Francisco; and Department of Anesthesiology and Department of Biomedical Engineering, Northwestern University, Chicago, IL (M.E., J.A.H.).
  • Neha Mantri
    UCSF Department of Medicine, Division of Cardiology, San Francisco, California.
  • Benjamin Rubin
    Bakar Computation Health Sciences Institute, University of California, San Francisco, San Francisco, California.
  • Joshua Barrios
    Division of Cardiology, University of California-San Francisco, San Francisco, California, USA.
  • Christel Chehoud
    Janssen Pharmaceuticals, Inc, Raritan, New Jersey.
  • Emily Kogan
    Janssen Research & Development, LLC, Raritan, NJ, USA. ekogan@its.jnj.com.
  • Xavier Gitton
    Actelion Pharmaceuticals Ltd., Allschwil, Switzerland.
  • Anderson Nnewihe
    Janssen Pharmaceuticals, Inc, Raritan, New Jersey.
  • Deborah Quinn
    Janssen Pharmaceuticals, Inc, Raritan, New Jersey.
  • Charles Bridges
    Janssen Pharmaceuticals, Inc, Raritan, New Jersey.
  • Atul J Butte
    Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA.
  • Jeffrey E Olgin
    Division of Cardiology, Hypertrophic Cardiomyopathy Center of Excellence, University of California San Francisco, San Francisco, California.
  • Geoffrey H Tison
    Department of Medicine (G.H.T., M.H.L., E.F., M.A.A., C.J., K.E.F., R.C.D.).